JPS5014683A - - Google Patents

Info

Publication number
JPS5014683A
JPS5014683A JP49057387A JP5738774A JPS5014683A JP S5014683 A JPS5014683 A JP S5014683A JP 49057387 A JP49057387 A JP 49057387A JP 5738774 A JP5738774 A JP 5738774A JP S5014683 A JPS5014683 A JP S5014683A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP49057387A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5014683A publication Critical patent/JPS5014683A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60—N-oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
JP49057387A 1973-06-15 1974-05-23 Pending JPS5014683A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37034073A 1973-06-15 1973-06-15

Publications (1)

Publication Number Publication Date
JPS5014683A true JPS5014683A (ja) 1975-02-15

Family

ID=23459225

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49057387A Pending JPS5014683A (ja) 1973-06-15 1974-05-23

Country Status (7)

Country Link
JP (1) JPS5014683A (ja)
BE (1) BE816355A (ja)
DE (1) DE2428194A1 (ja)
FR (1) FR2233060B1 (ja)
GB (1) GB1443602A (ja)
NL (1) NL7407821A (ja)
ZA (1) ZA743270B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1416872A (en) * 1972-03-10 1975-12-10 Wyeth John & Brother Ltd 4-aminoquinoline derivatives

Also Published As

Publication number Publication date
BE816355A (fr) 1974-12-16
DE2428194A1 (de) 1975-01-09
NL7407821A (ja) 1974-12-17
FR2233060B1 (ja) 1978-07-28
GB1443602A (en) 1976-07-21
FR2233060A1 (ja) 1975-01-10
ZA743270B (en) 1975-05-28

Similar Documents

Publication Publication Date Title
AU476761B2 (ja)
AU474593B2 (ja)
AU474511B2 (ja)
AU474838B2 (ja)
AU471343B2 (ja)
AU476714B2 (ja)
AU472848B2 (ja)
AU476696B2 (ja)
AU466283B2 (ja)
FR2233060B1 (ja)
AU477823B2 (ja)
AU471461B2 (ja)
AU477824B2 (ja)
AR193950A1 (ja)
AU476873B1 (ja)
CH559848A5 (ja)
AU479405A (ja)
BG19068A1 (ja)
BG18902A1 (ja)
BG18723A1 (ja)
AU479903A (ja)
AU479562A (ja)
AU479539A (ja)
AU479522A (ja)
AU479521A (ja)